M&A in the Med Spa Sector: The Consolidation Wave Is Just Getting Started
The medical aesthetics M&A market hit record deal volume in 2025 and shows no signs of slowing. Here is who is buying, what they are paying, and what it means for independent operators and franchisees alike.
The medical aesthetics M&A market has never been more active. Deal volume in 2025 exceeded $4 billion across private equity acquisitions, strategic consolidations, and franchise system sales — a record that analysts expect 2026 to surpass.
The consolidation wave that has been building for five years is now in full acceleration. Understanding it is essential for anyone who owns, operates, or is considering investing in a med spa or spa franchise.
The Buyer Landscape
The medical aesthetics M&A market has three distinct buyer categories, each with different acquisition criteria, valuation approaches, and post-acquisition strategies.
Private equity platform builders are the most active buyers in the market. These are PE firms that have identified the medical aesthetics sector as a consolidation opportunity and are building platforms through a combination of anchor acquisitions and add-on deals. They are looking for: proven unit economics, scalable operating systems, strong management teams, and geographic density that creates operational leverage.
Key PE buyers active in the space include L Catterton (which has backed Ideal Image and Restore Hyper Wellness), Warburg Pincus (Sola Salons), and a growing number of lower-middle-market PE firms targeting regional med spa chains with 5 to 20 locations.
Strategic acquirers — existing med spa chains and franchise systems looking to expand through acquisition rather than organic growth — are the second major buyer category. These buyers value geographic expansion, customer base acquisition, and the ability to convert acquired locations to their brand and operating system. They typically pay lower multiples than PE buyers but can close faster and with less complexity.
Family offices and high-net-worth individuals are increasingly active in the med spa M&A market, particularly for single-location and small multi-location acquisitions. These buyers are often looking for cash-flowing businesses with strong management teams that can operate with limited owner involvement. They typically pay 3 to 5 times SDE for single-unit acquisitions.
What Buyers Are Paying
Valuation multiples in the medical aesthetics M&A market have expanded significantly over the past five years, driven by PE competition and the sector's strong fundamental performance.
Single-location independent med spas are trading at 3 to 5 times SDE, with the multiple driven primarily by revenue quality (membership vs. transaction), management depth, and lease terms.
Multi-location regional chains (5 to 20 locations) are trading at 5 to 8 times EBITDA, with the higher multiple reflecting the operational leverage and scalability that PE buyers are specifically seeking.
Franchise systems (the franchisor itself, not individual franchise locations) are trading at 8 to 15 times EBITDA, reflecting the asset-light nature of the franchise model and the recurring royalty revenue stream.
These multiples represent a significant premium over where the sector traded in 2019 and 2020. The premium is justified by the sector's demonstrated resilience, the recurring revenue characteristics of membership models, and the continued demographic tailwinds driving demand growth.
What Sellers Need to Know
If you own a med spa — whether independent or franchise — and are considering a sale in the next three to five years, the current market environment is as favorable as it has ever been. But maximizing your exit requires preparation.
EBITDA quality is the primary value driver. Buyers are buying earnings, not revenue. Clean financials, well-documented add-backs, and a clear path to EBITDA growth post-acquisition are the factors that move you from the middle of the multiple range to the top.
Management depth is increasingly important. PE buyers in particular are looking for businesses that can operate without the owner. If your business is dependent on your personal relationships with customers or your direct clinical involvement, you need to build management depth before going to market.
Membership data is scrutinized. Active member count, monthly churn rate, average member tenure, and membership revenue as a percentage of total revenue are all metrics that sophisticated buyers will model in detail. Clean, well-organized membership data accelerates due diligence and supports higher valuations.
The process matters. Running a competitive sale process — with multiple qualified buyers, a well-prepared information memorandum, and professional representation — consistently produces better outcomes than accepting the first offer from the first buyer who approaches you.
The Window Is Open — But Not Forever
The current M&A environment in the medical aesthetics sector is exceptional by historical standards. PE capital is abundant, strategic buyers are active, and the sector's fundamental performance continues to attract new capital.
But M&A cycles are cyclical. Interest rate changes, PE fund cycles, and sector-specific events can shift the market quickly. Sellers who are prepared to move when the market is favorable will capture the premium that the current environment supports.
BIZLINX.ai's AI Exit Score™ gives you an instant assessment of your business's exit readiness across 25 dimensions — free. It is the starting point for any med spa owner thinking about a future sale.
Explore Topics
Written by
BIZLINX.ai Team
Content creator and writer sharing insights and stories.